Evidence map›Paper›PMID 37363646›Full record

ReviewBiologia2023

The dual role of fucosidases: tool or target.

Carlos Jiménez-Pérez, Francisco Guzmán-Rodríguez, Alma E Cruz-Guerrero, Sergio Alatorre-Santamaría

Open access · bronzeAbstract readReview
In one paragraph

Review in Biologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carlos Jiménez-PérezDpto. de Biotecnología, Universidad Autónoma Metropolitana Unidad Iztapalapa, C.P. 09340 Mexico City, Mexico.ORCID 0000-0002-4030-7491
Francisco Guzmán-RodríguezDpto. de Biotecnología, Universidad Autónoma Metropolitana Unidad Iztapalapa, C.P. 09340 Mexico City, Mexico.ORCID 0000-0002-3932-8463
Alma E Cruz-GuerreroDpto. de Biotecnología, Universidad Autónoma Metropolitana Unidad Iztapalapa, C.P. 09340 Mexico City, Mexico.ORCID 0000-0002-9686-2267
Sergio Alatorre-SantamaríaDpto. de Biotecnología, Universidad Autónoma Metropolitana Unidad Iztapalapa, C.P. 09340 Mexico City, Mexico.ORCID 0000-0001-6251-7855
Universidad Autónoma Metropolitana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regular intake of fucosylated oligosaccharides has been associated with several benefits for human health, particularly for new-borns. Since these biologically active molecules can be found naturally in human milk, research efforts have been focused on the alternative synthetic routes leading to their production. In particular, utilization of fucosidases to perform stereoselective transglycosylation reactions has been widely investigated. Other reasons that bring these enzymes to the spotlight are their role in viral infections and cancer proliferation. Since their involvement in the pathogenesis of these diseases have been widely described, fucosidases have become a target in newly developed therapies. Finally, activity disorders of biologically important fucosidases can lead to health problems such as fucosidosis. What is common for both mechanisms is the interaction between the enzyme and substrates in and around the active site. Therefore, this review will analyse different substrate structures that have been tested in terms of their interaction with fucosidases active sites, either in synthesis or inhibition reactions. The published results will be compared from this perspective.

Indexed as

Active siteEnzymatic activityFucosidasesIntermolecular interactions

Identifiers

PMID37363646
PMCPMC9972328
OpenAlexW4322627616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.